Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-12 Sale | 2025-03-14 4:25 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 15,470 | $328.54 | $5,082,480 | 391,289 (Indirect Direct) | View |
| 2025-03-10 Sale | 2025-03-12 4:32 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 258 | $323.04 | $83,344 | 10,440 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 5:40 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 14,113 | $341.32 | $4,817,104 | 14,383 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:36 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 415 | $335 | $139,025 | 7,290 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:31 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 1,961 | $324.96 | $637,248 | 6,914 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:24 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 1,834 | $325.98 | $597,840 | 8,604 (Direct) | View |
| 2025-02-28 Sale | 2025-03-04 9:24 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,227 | $341.07 | $418,488 | 3,728 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:31 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 15,470 | $347.45 | $5,375,126 | 1,912 (Direct) | View |
| 2025-02-27 Sale | 2025-02-28 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 20,000 | $356.44 | $7,128,759 | 7,382 (Direct) | View |
| 2025-01-24 Sale | 2025-01-27 5:18 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 347 | $335.24 | $116,328 | 10,438 (Direct) | View |
| 2025-01-24 Sale | 2025-01-27 5:12 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 1,584 | $335.24 | $531,020 | 54,303 (Direct) | View |
| 2025-01-24 Sale | 2025-01-27 5:07 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 648 | $335.24 | $217,236 | 1,112,202 (Indirect Direct) | View |
| 2025-01-24 Sale | 2025-01-27 5:03 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 103 | $335.24 | $34,530 | 4,955 (Direct) | View |
| 2025-01-17 Sale | 2025-01-17 7:10 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 277 | $273.41 | $75,735 | 7,705 (Direct) | View |
| 2025-01-17 Sale | 2025-01-17 7:08 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 442 | $273.41 | $120,847 | 5,058 (Direct) | View |
| 2025-01-17 Sale | 2025-01-17 7:05 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 1,689 | $273.41 | $461,789 | 1,112,850 (Indirect Direct) | View |
| 2024-12-03 Sale | 2024-12-05 4:46 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 3,600 | $315.31 | $1,135,122 | 383,547 (Indirect Direct) | View |
| 2024-11-25 Sale | 2024-11-27 4:16 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 3,400 | $350.3 | $1,191,028 | 387,147 (Indirect Direct) | View |
| 2024-11-21 Sale | 2024-11-22 4:30 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 688 | $316.92 | $218,041 | 10,785 (Direct) | View |
| 2024-11-07 Sale | 2024-11-08 5:07 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $350 | $1,750,000 | 16,012 (Direct) | View |
| 2024-11-01 Sale | 2024-11-05 7:01 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $300.94 | $1,504,703 | 21,012 (Direct) | View |
| 2024-09-09 Sale | 2024-09-11 9:51 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 6,363 | $243.83 | $1,551,490 | 55,887 (Direct) | View |
| 2024-06-14 Sale | 2024-06-18 9:39 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,900 | $280 | $532,000 | 15,850 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-12 Exercise | 2025-03-14 4:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 6,000 | $111.06 | 391,289 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-14 4:25 pm | N/A 2025-06-16 | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 15,470 | $0 | 391,289 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-14 4:25 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 9,470 | $65.06 | 391,289 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:29 pm | N/A 2035-03-10 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FOUSE JACQUALYN A Director | 2,473 | $0 | 2,473 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:47 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 35,075 | $0 | 139,378 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:43 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Dier Mardi SVP and CFO | 10,158 | $0 | 17,072 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:40 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 3,218 | $0 | 14,383 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:40 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 6,825 | $87.92 | 14,383 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:40 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 7,288 | $87.09 | 14,383 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 5:40 pm | N/A 2031-08-02 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 14,113 | $0 | 14,383 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 5:00 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 11,763 | $0 | 1,123,965 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:50 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 8,555 | $0 | 15,845 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:31 pm | N/A 2035-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Huntsman Carole Chief Commercial Officer | 9,089 | $0 | 17,693 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:36 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Sibold William John President and CEO | 50,000 | $0 | 104,303 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:31 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 6,000 | $111.06 | 1,912 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:31 pm | N/A 2025-06-16 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 15,470 | $0 | 1,912 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:31 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 9,470 | $65.06 | 1,912 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 4,530 | $9.45 | 7,382 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 6,000 | $111.06 | 7,382 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 20,000 | $0 | 7,382 (Direct) | View |
| 2025-02-27 Exercise | 2025-02-28 4:30 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 9,470 | $65.06 | 7,382 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 5:07 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $7.36 | 16,012 (Direct) | View |
| 2024-11-07 Exercise | 2024-11-08 5:07 pm | N/A 2026-08-11 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $0 | 16,012 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-05 7:01 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $7.36 | 21,012 (Direct) | View |
| 2024-11-01 Exercise | 2024-11-05 7:01 pm | N/A 2026-08-11 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 5,000 | $0 | 21,012 (Direct) | View |
| 2024-09-13 Gift | 2024-09-17 8:36 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 15,000 | $0 | 390,547 (Direct) | View |
| 2024-08-15 Option Award | 2024-08-19 8:16 pm | N/A 2034-08-15 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 13,035 | $0 | 15,802 (Direct) | View |
Ownership | 2024-08-15 7:52 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Kelley Shannon T General Counsel | 0 | $0 | 6,936 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:46 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director | 1,819 | $0 | 406,652 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:45 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 1,819 | $0 | 3,017 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:42 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director | 1,819 | $0 | 3,017 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:42 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director | 1,819 | $0 | 12,117 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 9:41 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director | 1,819 | $0 | 843,094 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-27 5:03 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 5,848 | $0 | 1,799,251 (Indirect) | View |
| 2024-06-14 Exercise | 2024-06-18 9:39 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,900 | $87.09 | 15,850 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-18 9:39 pm | N/A 2032-02-24 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. | 1,900 | $0 | 15,850 (Direct) | View |